Systemic Drug Therapy for Restenosis-Reference-Cited by-同舟云学术

Systemic Drug Therapy for Restenosis

Published:2002-10-29 Issue:18 Volume:106 Page:2296-2298
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Faxon David P.¹

Affiliation:

1. From the Section of Cardiology, University of Chicago, Chicago, Ill.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000038412.38399.D5

Reference13 articles.

1. Oral Everolimus Inhibits In-Stent Neointimal Growth

2. A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

3. Mody VH Durairaj A Mehra AO. Pharmacological approaches to prevent restenosis.In Faxon DP ed. Restenosis: A Guide to Therapy. London UK: Martin Durnitz; 2001: 97–112.

4. Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polydopamine-Modified Copper-Doped Titanium Dioxide Nanotube Arrays for Copper-Catalyzed Controlled Endogenous Nitric Oxide Release and Improved Re-Endothelialization;ACS Applied Bio Materials;2020-04-14

2. Remote targeted implantation of sound-sensitive biodegradable multi-cavity microparticles with focused ultrasound;Scientific Reports;2019-07-03

3. Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases;Drug Delivery and Translational Research;2017-10-20

4. Application of Quality by Design (QbD) Approach to Ultrasonic Atomization Spray Coating of Drug-Eluting Stents;AAPS PharmSciTech;2015-01-07

5. Nanotechnology Applications in Local Arterial Drug Delivery;Advances in Delivery Science and Technology;2013-12-24